Details of the Drug

General Information of Drug (ID: DMA4SIN)

Drug Name
HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE
Synonyms N-hydroxy-N-[3-(6-methylpyridin-2-yl)propyl]formamide; SB-505684; HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE; SB9; AC1NRD3B; BDBM21685
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 194.23
Logarithm of the Partition Coefficient (xlogp) 0.9
Rotatable Bond Count (rotbonds) 4
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C10H14N2O2
IUPAC Name
N-hydroxy-N-[3-(6-methylpyridin-2-yl)propyl]formamide
Canonical SMILES
CC1=NC(=CC=C1)CCCN(C=O)O
InChI
InChI=1S/C10H14N2O2/c1-9-4-2-5-10(11-9)6-3-7-12(14)8-13/h2,4-5,8,14H,3,6-7H2,1H3
InChIKey
FJYUGRZKJXCRFF-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
5289331
DrugBank ID
DB08525
TTD ID
D02XIF

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Staphylococcus Peptide deformylase (Stap-coc def) TTICO5G DEF_STAAU Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.